| Market Cap | 97.96B | P/E | 25.39 | EPS this Y | -19.90% | Ern Qtrly Grth | -47.90% |
| Income | 7.32B | Forward P/E | 8.63 | EPS next Y | 11.40% | 50D Avg Chg | 8.00% |
| Sales | 359.66B | PEG | 3.99 | EPS past 5Y | 1.51% | 200D Avg Chg | -7.00% |
| Dividend | 3.00% | Price/Book | 1.35 | EPS next 5Y | 2.06% | 52W High Chg | -29.00% |
| Recommedations | 2.30 | Quick Ratio | 0.54 | Shares Outstanding | 1.26B | 52W Low Chg | 15.00% |
| Insider Own | 0.12% | ROA | 3.18% | Shares Float | 1.25B | Beta | 0.55 |
| Inst Own | 82.21% | ROE | 10.09% | Shares Shorted/Prior | 13.71M/22.72M | Price | 76.41 |
| Gross Margin | 14.55% | Profit Margin | 2.04% | Avg. Volume | 9,103,375 | Target Price | 68.76 |
| Oper. Margin | 2.13% | Earnings Date | Jul 31 | Volume | 22,288,463 | Change | 3.33% |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
| Argus Research | Buy | May 8, 24 |
| Wells Fargo | Equal-Weight | May 7, 24 |
| TD Cowen | Hold | May 7, 24 |
| B of A Securities | Buy | May 2, 24 |
| Goldman Sachs | Buy | May 2, 24 |
| Barclays | Equal-Weight | May 2, 24 |
| UBS | Neutral | May 2, 24 |
| Truist Securities | Buy | May 2, 24 |
| Mizuho | Buy | May 2, 24 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Clark James David | SVP, Cont & Chief Ac.. SVP, Cont & Chief Acct Officer | Aug 03 | Sell | 74.87 | 25,759 | 1,928,595 | 4,698 | 08/04/23 |
| Lotvin Alan | EVP&President-Pharma.. EVP&President-PharmacyServices | Aug 03 | Option | 58.25 | 143,440 | 8,355,380 | 131,724 | 08/05/22 |
| Lotvin Alan | EVP&President-Pharma.. EVP&President-PharmacyServices | Aug 03 | Sell | 100 | 143,440 | 14,344,000 | 109,183 | 08/05/22 |
| Finke Daniel P | EVP/Pres, Health Car.. EVP/Pres, Health Care Benefits | Aug 03 | Option | 52.37 | 9,546 | 499,924 | 41,696 | 08/05/22 |
| Finke Daniel P | EVP/Pres, Health Car.. EVP/Pres, Health Care Benefits | Aug 03 | Sell | 100 | 9,546 | 954,600 | 32,150 | 08/05/22 |
| Moriarty Thomas M | EVP & General Counse.. EVP & General Counsel | Jun 28 | Option | 62.28 | 138,654 | 8,635,371 | 665,146 | 06/30/22 |
| Moriarty Thomas M | EVP & General Counse.. EVP & General Counsel | Jun 28 | Sell | 95 | 138,654 | 13,172,130 | 626,273 | 06/30/22 |
| Shah Prem S | EVP and Co-President.. EVP and Co-President of Retail | Apr 08 | Option | 62.26 | 13,824 | 860,682 | 50,686 | 04/12/22 |
| Shah Prem S | EVP and Co-President.. EVP and Co-President of Retail | Apr 08 | Sell | 105 | 16,954 | 1,780,170 | 43,453 | 04/12/22 |
| Finke Daniel P | EVP/Pres, Health Car.. EVP/Pres, Health Care Benefits | Apr 04 | Option | 56.27 | 43,327 | 2,438,010 | 77,289 | 04/06/22 |
| Finke Daniel P | EVP/Pres, Health Car.. EVP/Pres, Health Care Benefits | Apr 04 | Sell | 100.1 | 61,300 | 6,136,130 | 32,150 | 04/06/22 |
| Shah Prem S | EVP and Co-President.. EVP and Co-President of Retail | Mar 30 | Option | 102.26 | 5,346 | 546,682 | 64,417 | 03/31/22 |
| Shah Prem S | EVP and Co-President.. EVP and Co-President of Retail | Mar 30 | Sell | 104.7 | 5,346 | 559,726 | 59,071 | 03/31/22 |
| Shah Prem S | EVP and Co-President.. EVP and Co-President of Retail | Mar 17 | Option | 104.82 | 2,935 | 307,647 | 62,006 | 03/18/22 |
| Shah Prem S | EVP and Co-President.. EVP and Co-President of Retail | Mar 17 | Sell | 106.65 | 4,624 | 493,150 | 59,071 | 03/18/22 |
| LUDWIG EDWARD J | Director Director | Feb 10 | Buy | 105.9044 | 1,000 | 105,904 | 18,334 | 02/11/22 |
| Brennan Troyen A | EVP and Chief Medica.. EVP and Chief Medical Officer | Feb 03 | Sell | 110 | 47,937 | 5,273,070 | 138,246 | 02/04/22 |
| Brennan Troyen A | EVP and Chief Medica.. EVP and Chief Medical Officer | Feb 03 | Option | 102.26 | 47,937 | 4,902,038 | 186,183 | 02/04/22 |
| Clark James David | SVP, Cont & Chief Ac.. SVP, Cont & Chief Acct Officer | Jan 28 | Option | 102.26 | 6,059 | 619,593 | 23,556 | 02/01/22 |
| Clark James David | SVP, Cont & Chief Ac.. SVP, Cont & Chief Acct Officer | Jan 28 | Sell | 109 | 6,059 | 660,431 | 17,497 | 02/01/22 |
| Roberts Jonathan C | EVP & Chief Operatin.. EVP & Chief Operating Officer | Jan 27 | Option | 102.26 | 68,482 | 7,002,969 | 175,597 | 01/28/22 |
| Roberts Jonathan C | EVP & Chief Operatin.. EVP & Chief Operating Officer | Jan 27 | Sell | 107.5 | 68,482 | 7,361,815 | 107,115 | 01/28/22 |
| Clark James David | SVP, Cont & Chief Ac.. SVP, Cont & Chief Acct Officer | Apr 01 | Option | 74.29 | 5,350 | 397,452 | 12,594 | 04/01/21 |
| Clark James David | SVP, Cont & Chief Ac.. SVP, Cont & Chief Acct Officer | Apr 01 | Sell | 76 | 5,350 | 406,600 | 7,244 | 04/01/21 |
| Roberts Jonathan C | EVP & Chief Operatin.. EVP & Chief Operating Officer | Mar 29 | Sell | 74.49 | 73,433 | 5,470,024 | 664 | 03/29/21 |
| Roberts Jonathan C | EVP & Chief Operatin.. EVP & Chief Operating Officer | Mar 29 | Option | 74.29 | 73,433 | 5,455,338 | 74,097 | 03/29/21 |
| MERLO LARRY J | Director Director | Mar 29 | Option | 74.29 | 271,347 | 20,158,369 | 794,676 | 03/29/21 |
| MERLO LARRY J | Director Director | Mar 29 | Sell | 74.73 | 270,650 | 20,225,674 | 524,026 | 03/29/21 |
| Bisaccia Lisa | EVP and Chief HR Off.. EVP and Chief HR Officer | Jan 13 | Option | 74.29 | 25,177 | 1,870,399 | 71,765 | 01/13/21 |
| Bisaccia Lisa | EVP and Chief HR Off.. EVP and Chief HR Officer | Jan 13 | Sell | 77 | 25,177 | 1,938,629 | 46,588 | 01/13/21 |
| Lotvin Alan | EVP and President-CV.. EVP and President-CVS Caremark | Jan 12 | Option | 64.24 | 25,836 | 1,659,705 | 34,205 | 01/12/21 |
| Lotvin Alan | EVP and President-CV.. EVP and President-CVS Caremark | Jan 12 | Sell | 75 | 25,836 | 1,937,700 | 8,369 | 01/12/21 |
| Brennan Troyen A | EVP and Chief Medica.. EVP and Chief Medical Officer | Jan 12 | Option | 74.29 | 54,550 | 4,052,520 | 100,558 | 01/12/21 |
| Brennan Troyen A | EVP and Chief Medica.. EVP and Chief Medical Officer | Jan 12 | Sell | 75 | 58,896 | 4,417,200 | 46,008 | 01/12/21 |